203 related articles for article (PubMed ID: 4038580)
1. Current state of infectious diseases--potential areas of directed therapy with aztreonam.
Neu HC
Am J Med; 1985 Feb; 78(2A):77-80. PubMed ID: 4038580
[TBL] [Abstract][Full Text] [Related]
2. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
Henry SA; Bendush CB
Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
[TBL] [Abstract][Full Text] [Related]
3. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
Scully BE; Neu HC
Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
[TBL] [Abstract][Full Text] [Related]
4. Aztreonam.
Childs SJ; Bodey GP
Pharmacotherapy; 1986; 6(4):138-52. PubMed ID: 3534798
[TBL] [Abstract][Full Text] [Related]
5. Treatment of gram-negative infections with aztreonam.
Simons WJ; Lee TJ
Am J Med; 1985 Feb; 78(2A):27-30. PubMed ID: 4038577
[TBL] [Abstract][Full Text] [Related]
6. Aztreonam therapy for serious gram-negative bacillary infections.
Cone LA; Woodard DR
Rev Infect Dis; 1985; 7 Suppl 4():S794-802. PubMed ID: 3909339
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
[TBL] [Abstract][Full Text] [Related]
8. Ceftizoxime: clinical evaluation of efficacy and safety in the U.S.A.
Parks D; Layne P; Uri J; Ziv D; Bass S
J Antimicrob Chemother; 1982 Nov; 10 Suppl C():327-38. PubMed ID: 6296027
[No Abstract] [Full Text] [Related]
9. Aztreonam in the treatment of serious orthopedic infections.
Pribyl C; Salzer R; Beskin J; Haddad RJ; Pollock B; Beville R; Holmes B; Mogabgab WJ
Am J Med; 1985 Feb; 78(2A):51-6. PubMed ID: 3881949
[TBL] [Abstract][Full Text] [Related]
10. Aztreonam: the first monobactam.
Neu HC
Med Clin North Am; 1988 May; 72(3):555-66. PubMed ID: 3280906
[TBL] [Abstract][Full Text] [Related]
11. Aztreonam: the first monobactam.
Sykes RB; Bonner DP
Am J Med; 1985 Feb; 78(2A):2-10. PubMed ID: 3871589
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
McKellar PP
Rev Infect Dis; 1985; 7 Suppl 4():S803-9. PubMed ID: 3909340
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
Clergeot A; Steru D; Rosset MA; Carbon C
Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476
[TBL] [Abstract][Full Text] [Related]
14. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
Rabinad E; Bosch-Perez A
Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
[TBL] [Abstract][Full Text] [Related]
15. Third-generation cephalosporins: a critical evaluation.
Barriere SL; Flaherty JF
Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity, pharmacokinetics, therapeutic indications and adverse reactions of ceftazidime.
Gentry LO
Pharmacotherapy; 1985; 5(5):254-67. PubMed ID: 3906585
[TBL] [Abstract][Full Text] [Related]
17. Infections due to gram-negative bacteria: an overview.
Neu HC
Rev Infect Dis; 1985; 7 Suppl 4():S778-82. PubMed ID: 3909337
[TBL] [Abstract][Full Text] [Related]
18. Treatment of common infectious disorders.
Kalis PM; Le Frock JL; Prince RA; Jacknowitz AI
W V Med J; 1976 Jun; 72(6):135-45. PubMed ID: 1064245
[No Abstract] [Full Text] [Related]
19. Empiric antibiotic use--aztreonam as a model.
Levin S
Am J Med; 1990 Mar; 88(3C):21S-23S; discussion 38S-42S. PubMed ID: 2316555
[TBL] [Abstract][Full Text] [Related]
20. Aztreonam.
Clark P
Obstet Gynecol Clin North Am; 1992 Sep; 19(3):519-28. PubMed ID: 1436929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
